相关实验视频

Updated: Jun 28, 2026

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

设计和合成FR-β向化学分子用于重编程与瘤相关的巨细胞,使用6-替代Pyrrolo[2,3-d]pyrimidines作为向联体

Lixiao Guo¹, Binghao Guo¹, Yuqing Wang¹

¹Department of Medicinal Chemistry, School of Pharmacy, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang 050017, PR China.

Journal of medicinal chemistry

|April 12, 2025

概括

研究人员开发了针对瘤相关巨细胞 (TAMs) 的新型嵌合分子,以增强癌症免疫疗法. 这些分子重编程TAMs,抑制瘤生长,并显示出治疗各种固体瘤的潜力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药物发现药物发现药物发现

背景情况:

瘤相关巨细胞 (TAMs) 是瘤微环境中的关键免疫细胞.
重编程TAM是有效的抗瘤免疫疗法的有希望的策略.
像IMDQ这样的现有免疫调节剂缺乏点特异性,限制了它们的临床应用.

研究的目的:

开发用于有针对性的TAM重编程的新型化学分子.
通过使用叶酸受体β (FR-β) 向连接体来增强TLR7/8激素IMDQ的特异性.
评估这些化学分子在临床前癌症模型中的有效性和安全性.

主要方法:

新型FR-β向化学分子的设计和合成,其中包含6替代的pyrrolo[2,3-d]pyrimidines.
在体外和体内评估化学分子向TAM并调节其表型的能力.
在临床前模型中评估瘤进展和全身毒性.

主要成果:

与叶酸相比,开发的化学分子表现出优异的FR-β向.
观察到TAMs被选择性地重新编程为一种免疫刺激的表型.
实现了显著的瘤进展抑制,没有系统性毒性.

结论:

使用新奇的化学分子对TAM进行有针对性的重编程是一种强大的抗瘤免疫疗法策略.
由于TAMs的流行,这种方法在治疗各种固体瘤方面具有广泛的适用性.
开发的化学分子代表了针对癌症免疫治疗的重大进步.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...